HRTX
Heron Therapeuti
0.3582$
-6.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
Heron Therapeuti (HRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.1 | -0.2 | -1.5 | -0.6 | -3.1 | -6.5 | -5.1 | -6.5 | -7.7 | -7.5 | 9.2 | -17 | -24 | -11 | -5.5 | -7.7 | -17 | -41 | -60 | -79 | -134 | -170 | -192 | -125 | -185 | -203 | -147 | -59 | -23 | -28 | |
| 1.4 | 1.2 | 1.4 | 0.5 | -0.1 | 0.4 | 0.5 | 0.5 | 0.3 | 0.4 | -0.2 | 0.3 | 0.4 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.6 | 0.7 | 1.1 | 1.5 | 1.5 | 2.0 | 2.8 | 3.0 | 2.9 | 2.9 | 2.5 | 2.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 1.1 | 1.1 | 1.7 | 1.9 | 5.7 | 11 | 8.1 | 14 | 26 | 31 | 33 | 51 | 50 | 47 | 43 | 33 | 13 | 10 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.4 | 1.1 | 11 | 9.0 | 14 | 26 | 31 | 33 | 52 | 51 | 48 | 43 | – | – | – | |
| 0.3 | -0.9 | -5.0 | -2.7 | -0.6 | -1.2 | -0.8 | -0.4 | 0.8 | -0.1 | 3.5 | 2.1 | -3.0 | -2.4 | -0.3 | 1.5 | 1.1 | 2.8 | 5.9 | 3.4 | 11 | -5.4 | -45 | 29 | -13 | -35 | -11 | 17 | -28 | -32 | |
| 0.7 | 2.8 | 2.7 | 0.3 | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.5 | 0.3 | 0.0 | 0.1 | 0.5 | 1.0 | 1.7 | 1.4 | 1.1 | 3.1 | 2.6 | 9.2 | 7.2 | 6.8 | 3.0 | 1.8 | 1.5 | 1.7 | 0.3 | |
| -0.7 | -1.0 | -2.8 | -0.4 | 9.0 | 3.5 | 4.7 | 3.3 | -1.3 | 5.1 | -7.7 | 11 | 0.7 | 0.6 | -0.1 | -0.5 | -1.0 | -1.7 | -1.4 | -57 | 15 | 7.7 | -279 | -22 | 209 | 33 | -3.3 | 18 | 19 | 16 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 61 | 62 | 138 | 7.5 | 319 | 383 | 186 | 9.1 | 7.1 | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.0 | – | 50 | 50 | 50 | -25 | -25 | 0.0 | 0.0 | 149 | 0.0 | 24 | 0.0 | -13 | |
| 7.1 | 4.3 | -0.3 | 0.6 | -3.1 | 0.1 | 0.1 | 0.1 | 12 | 0.1 | 0.1 | 37 | 0.1 | 8.0 | 0.1 | 24 | 54 | 61 | 62 | 138 | 57 | 294 | 358 | 186 | 9.1 | 156 | 75 | 54 | 0.9 | 14 | |
| 0.3 | 3.1 | -4.6 | -0.4 | 2.8 | -2.9 | -0.3 | -3.2 | 3.0 | 0.8 | 1.5 | 31 | -24 | -2.4 | -5.5 | 16 | 36 | 19 | 0.4 | 2.5 | -62 | 131 | -113 | 40 | 33 | -15 | -75 | 13 | -2.9 | 2.8 | |
| -6.8 | -3.0 | -4.2 | -0.9 | -3.3 | -6.8 | -5.6 | -6.8 | -7.9 | -7.8 | 9.0 | -18 | -25 | -11 | -5.6 | -8.2 | -18 | -42 | -62 | -80 | -137 | -173 | -201 | -132 | -192 | -206 | -149 | -60 | -24 | -28 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.